Multivitamins are the most commonly consumed dietary supplement in the United States, taken daily by approximately 31% of adults according to the 2023–2024 NHANES data. Americans spend $8.7 billion annually on multivitamins, according to the Nutrition Business Journal. Yet the U.S. Preventive Services Task Force (USPSTF) — after reviewing 84 studies involving more than 700,000 participants — concluded in 2022 that there is "insufficient evidence to recommend multivitamins for the prevention of cardiovascular disease, cancer, or all-cause mortality."
This does not mean multivitamins are useless. It means the grand promise — take one pill and prevent major disease — is unsupported. The more relevant question for most consumers is narrower and more practical: does your multivitamin contain what the label claims, is it in forms your body can actually absorb, and is it free of contaminants that could cause harm?
The Quality Problem: What Independent Testing Reveals
ConsumerLab's 2024 multivitamin review — the most comprehensive third-party evaluation, conducted annually since 2000 — tested 54 multivitamin products available in the U.S. market. Approximately one-third failed to meet one or more label claims. The failure modes were consistent with patterns observed across the supplement industry:
Vitamin D content below labeled amount was the most frequent deficiency. Several products contained less than 60% of the vitamin D listed on the label — a significant shortfall for consumers who rely on their multivitamin to address inadequate sunlight exposure or dietary intake. Vitamin D degrades when exposed to heat, light, and humidity, making storage and manufacturing conditions critical. Products with longer shelf lives or stored in warm warehouses are at higher risk.
Degraded folic acid from poor manufacturing or storage conditions. Folic acid is chemically unstable and degrades through oxidation, particularly in the presence of moisture. Products that sat in warehouses or on retail shelves for extended periods showed lower folic acid content than freshly manufactured lots.
Excessive preformed vitamin A (retinol) exceeding the Tolerable Upper Intake Level of 3,000 mcg RAE. Chronic excess preformed vitamin A is hepatotoxic and increases fracture risk — a 2023 updated review in The American Journal of Clinical Nutrition (k=12 prospective studies, n=310,000) confirmed a dose-dependent increase in hip fracture risk at retinol intakes above 1,500 mcg RAE/day. Several tested products contained more than 3,000 mcg RAE of retinol, exceeding safe upper limits even before accounting for dietary intake.
Lead contamination above California's Proposition 65 threshold of 0.5 mcg/day. Lead accumulates in bone and soft tissue over decades and has no known safe threshold for chronic exposure. Several products, particularly those sourced from regions with lower manufacturing standards, exceeded this threshold.
The Regulatory Gap
Dr. Pieter Cohen, an internist at Harvard Medical School and the most prominent academic researcher on dietary supplement safety in the United States, describes the U.S. supplement market as "the Wild West of consumer health products." Under the 1994 Dietary Supplement Health and Education Act (DSHEA), supplement manufacturers are not required to prove efficacy, demonstrate safety, or verify label accuracy before selling their products. The FDA can act only after a product reaches the market and problems are reported — a reactive system that leaves consumers unprotected during the period of initial and often widest distribution.
This regulatory structure is unique among developed nations. The European Union requires pre-market notification and imposes maximum permitted levels for vitamins and minerals. Japan requires functional foods to demonstrate efficacy through human clinical trials. In the United States, the burden of proof falls on the consumer to determine whether a product is safe and accurately labeled — a determination that requires the kind of analytical chemistry most consumers cannot perform.
Third-party testing programs — USP, NSF International, ConsumerLab, Informed Sport — fill this gap by independently verifying product quality. USP verification is the most rigorous: it tests for identity (the product contains the correct ingredients), potency (amounts match the label within specified tolerances), purity (no harmful levels of contaminants including heavy metals, pesticides, and microbial pathogens), and dissolution (the product breaks down in simulated gastrointestinal fluid within the time specified by USP standards, ensuring bioavailability). The USP mark on a product means it has passed all four tests. Fewer than 1% of supplement products carry it.
Bioavailability: Forms That Matter
Not all chemical forms of the same vitamin or mineral are equally absorbed. The differences are large enough to determine whether a multivitamin provides meaningful nutritional support or expensive urine. Dr. Tod Cooperman, founder of ConsumerLab.com and the most prolific independent supplement tester in the United States, identifies four critical form choices in a quality multivitamin:
Methylfolate (5-MTHF) rather than folic acid. Approximately 30% of the population carries one or two copies of the MTHFR C677T polymorphism, which impairs the conversion of synthetic folic acid to its active form (5-methyltetrahydrofolate) by 30–70%. Methylfolate bypasses this conversion step entirely. A 2014 Nutrients review (k=11 studies) confirmed equivalent or superior bioavailability of 5-MTHF compared to folic acid, with the additional advantage that unmetabolized folic acid — which accumulates in the bloodstream when synthetic folic acid exceeds the body's conversion capacity — does not occur with methylfolate. The clinical significance of circulating unmetabolized folic acid remains debated, but avoiding it has no downside.
Vitamin D3 (cholecalciferol) rather than D2 (ergocalciferol). D3 is 60–87% more effective at raising serum 25(OH)D levels, per a 2012 American Journal of Clinical Nutrition meta-analysis (k=7 RCTs). D3 is the form produced by human skin in response to sunlight and has a longer half-life than D2. Most quality multivitamins now use D3; D2 is primarily found in budget products and those marketed as vegan (D3 was historically derived from sheep lanolin, though lichen-derived vegan D3 is now widely available).
Chelated minerals (citrate, glycinate, bisglycinate) rather than oxide forms. Magnesium oxide, the cheapest and most common form in multivitamins, has a bioavailability of approximately 4% — meaning 96% of the magnesium passes through the GI tract unabsorbed. Magnesium citrate and glycinate have 2–4× higher bioavailability, per a 2003 Journal of the American College of Nutrition study. The same principle applies to zinc (gluconate or picolinate over oxide) and iron (bisglycinate over sulfate, with the additional benefit of significantly less GI distress).
Mixed tocopherols for vitamin E rather than dl-alpha-tocopherol. The synthetic form (dl-alpha-tocopherol) has half the biological activity of the natural form (d-alpha-tocopherol), and the body preferentially retains the natural form. Mixed tocopherols more closely approximate the vitamin E profile obtained from food.
Who Actually Benefits From a Multivitamin
The USPSTF recommendation against multivitamins for general disease prevention has been widely misinterpreted as a recommendation against all supplementation. The actual clinical picture is more nuanced.
Populations with documented benefit from multivitamin supplementation include: adults consuming fewer than 1,800 kcal/day (common during caloric restriction or in older adults with reduced appetite), individuals on restrictive diets (vegan, elimination diets, food allergy diets) that exclude entire food groups, pregnant or planning-to-become-pregnant women (prenatal formulations with adequate folate, iron, and DHA), adults over 65 (who absorb B12 and D less efficiently from food), and individuals with documented malabsorption conditions (celiac disease, inflammatory bowel disease, post-bariatric surgery).
Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the VITAL trial (n=25,871, randomized, placebo-controlled), notes that the COSMOS-Mind sub-study found that daily multivitamin supplementation for 3 years produced a statistically significant improvement in global cognition in adults aged 65+ — a finding published in The American Journal of Clinical Nutrition in 2022 and replicated in a second cohort in 2023. This is the strongest randomized evidence for a multivitamin benefit to date, though the effect was modest and requires further confirmation.
What to Avoid
Several common multivitamin features are red flags for quality or safety:
Proprietary blends that list ingredients without disclosing individual amounts. This is a legal mechanism for including trace amounts of expensive ingredients (CoQ10, turmeric extract) that sound impressive on the label but are present in sub-therapeutic quantities.
Megadoses above 100% of the Daily Value for most nutrients, unless correcting a documented deficiency. Excess water-soluble vitamins (B-complex, vitamin C) are excreted in urine — expensive but generally harmless. Excess fat-soluble vitamins (A, D, E, K) accumulate in body tissue and can reach toxic levels. A 2021 JAMA Internal Medicine case series reported six cases of vitamin D toxicity (hypercalcemia) from supplements containing 50,000+ IU per dose.
Disease treatment or cure claims. Under DSHEA, supplements may not legally claim to treat, cure, or prevent any disease. A product whose label or marketing includes such claims is in violation of federal regulations — a signal that the manufacturer is willing to cut corners on compliance, which raises questions about manufacturing standards.
Artificial dyes (FD&C Red 40, Yellow 5, Blue 1). These serve no nutritional purpose and are associated with behavioral effects in sensitive children, per a 2012 Neurotherapeutics meta-analysis. They are a marker of manufacturing that prioritizes visual appeal over formulation quality.
The Evidence-Based Approach
The most defensible approach, supported by the weight of the evidence: use a basic, third-party tested (USP or NSF verified) multivitamin as nutritional insurance — a safety net for days when your diet falls short, not a substitute for eating well. Prioritize whole foods as primary nutrient sources, because food delivers nutrients in a matrix of fiber, phytochemicals, and co-factors that supplements cannot replicate.
Address specific documented deficiencies (vitamin D, iron, B12, folate) with targeted supplementation guided by blood work, not broad-spectrum megadosing. A serum 25(OH)D test ($30–50, widely available) tells you whether you need vitamin D supplementation and at what dose. A complete blood count with ferritin tells you whether you need iron. This targeted approach is more effective, less expensive, and safer than taking a multivitamin containing 800% of the Daily Value for 25 nutrients you do not need.
As Dr. Manson observes: "The supplements with the strongest evidence are the ones with the quietest marketing." A USP-verified, basic-formula multivitamin that costs $0.10 per day and makes no health claims is almost certainly a better product than one that costs $2.50 per day and promises to transform your health, optimize your energy, and unlock your potential.